Search
Abiraterone is a prostate cancer treatment.
Abiraterone is a targeted cytochrome CYP17 (17α-hydroxylase/C17,20-lyase) inhibitor that hydrolyzes to produce abiraterone, which reduces testosterone production by inhibiting cytochrome CYP17 and is indicated for the treatment of patients with castrated refractory prostate cancer (CRPC) who have previously received chemotherapy containing docetaxel.
Items | Specification | Result |
Appearance | White or off-white crystalline powder | White crystalline powder |
Assay(HPLC) | ≥99% | 99.7% |
Water | ≤0.5% | 0.31% |
Related substance | Single impurity≤0.5% Total impurity≤1.0% | 0.08% 0.27% |
Product parameters | |
Cas number: | 154229-19-3 |
Appearance: | White or off-white crystalline powder |
Purity: | 99%min |
Package details: | 100g,1kg/foil bag |
Brand: | Fortunachem |
Guaranteed purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: